To find the role of streptokinase in the management of loculated empyema and loculated parapneumonic effusion at tertiary centre.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: J90- Pleural effusion, not elsewhere classified
- Registration Number
- CTRI/2020/09/027834
- Lead Sponsor
- School of Medical Sciences Research and Sharda Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the patients, those will be diagnosed as loculated empyema and loculated parapneumonic effusion, willing to participate in this study having no exclusion criteria will be enrolled in this study.
Exclusion Criteria
1. Patients with duration of illness for more than 3 months.
2. Patients with previous history of pulmonary tuberculosis.
3. Patients with history of CAD and streptokinase infusion.
4. Patients not willing to participate in our study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plain computed tomographyTimepoint: On 7th day of intercostal drainage insertion
- Secondary Outcome Measures
Name Time Method SpirometryTimepoint: On 15th day of ICD insertion for improvement in forced vital capacity.